ctrl K

Price Alert

Oruka Therapeutics Inc. (ORKA)

NASDAQ: ORKA · Real-Time Price · USD

15.27

0.27 (1.80%)

At close: Aug 15, 2025, 2:58 PM

Oruka Therapeutics Balance Sheet Statement

Financials in USD. Fiscal year is undefined.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Cash & Equivalents	61.58M	37.43M	42.45M	53.36M
Short-Term Investments	314.07M	n/a	n/a	n/a
Long-Term Investments	18.07M	n/a	n/a	n/a
Other Long-Term Assets	43K	12K	18K	18K
Receivables	n/a	n/a	n/a	n/a
Inventory	n/a	n/a	n/a	n/a
Other Current Assets	1.22M	161K	254K	1.06M
Total Current Assets	376.87M	37.59M	42.7M	54.42M
Property-Plant & Equipment	1.04M	257K	368K	485K
Goodwill & Intangibles	n/a	n/a	n/a	n/a
Total Long-Term Assets	19.15M	269K	386K	503K
Total Assets	396.02M	37.86M	43.09M	54.92M
Account Payables	3.46M	n/a	334K	1.12M
Deferred Revenue	n/a	n/a	n/a	n/a
Short-Term Debt	213K	76K	103K	100K
Other Current Liabilities	7.33M	461K	522K	1.36M
Total Current Liabilities	13.04M	637K	1.13M	3.5M
Long-Term Debt	n/a	n/a	n/a	n/a
Other Long-Term Liabilities	n/a	n/a	n/a	n/a
Total Long-Term Liabilities	755K	204K	280K	383K
Total Liabilities	13.8M	841K	1.41M	3.88M
Total Debt	968K	280K	383K	483K
Common Stock	37K	14K	14K	14K
Retained Earnings	-83.72M	-188.74M	-183.4M	-173.48M
Comprehensive Income	-41K	n/a	n/a	n/a
Shareholders Equity	382.22M	37.02M	41.67M	51.04M
Total Investments	332.14M	n/a	n/a	n/a